Home › Funds › KVP Capital Advisors, LP › TNGX
KVP Capital Advisors, LP position in TNGX
TANGO THERAPEUTICS INC · Health Care
KVP Capital Advisors, LP reported holding 230,264 shares of TNGX (TANGO THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$5.7M, representing 4.70% of its reported portfolio and ranking #8 among its reported holdings. KVP Capital Advisors, LP has disclosed TNGX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How KVP Capital Advisors, LP's TNGX position evolved
KVP Capital Advisors, LP first disclosed a stake in TNGX in Q1 2026 at 230,264 shares (US$4.8M). The position peaked in Q2 2026 at 230,264 shares, worth US$7.2M. Across 3 filings, KVP Capital Advisors, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 230,264 shares valued at US$5.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 230.26K | $4.82M | New |
| Q2 2026 | 230.26K | $7.20M | Hold |
| Q3 2026 | 230.26K | $5.75M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TNGX and 13F data
TNGX (TANGO THERAPEUTICS INC) is a Health Care company. 70 other funds we track also report a position in TNGX — the largest reported positions include Farallon Capital Management (US$383.8M), RTW INVESTMENTS, LP (US$350.5M), Boxer Capital Management, LLC (US$340.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TNGX
- Farallon Capital Management 12.28M sh · $383.78M · Q2 2026
- RTW INVESTMENTS, LP 14.05M sh · $350.51M · Q3 2026
- Boxer Capital Management, LLC 10.88M sh · $339.99M · Q2 2026
- Paradigm Biocapital Advisors LP 6.96M sh · $173.69M · Q3 2026
- Siren, L.L.C. 6.78M sh · $169.26M · Q3 2026
- TCG Crossover Management, LLC 6.77M sh · $168.99M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 4.19M sh · $131.00M · Q2 2026
- TRV GP IV, LLC 6.37M sh · $120.18M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 4.55M sh · $113.54M · Q3 2026
- Deep Track Capital, LP 4.50M sh · $112.28M · Q3 2026
- PERCEPTIVE ADVISORS LLC 3.38M sh · $105.57M · Q2 2026
- Seven Fleet Capital Management LP 3.23M sh · $95.66M · Q2 2026
More on KVP Capital Advisors, LP
FAQ
How long has KVP Capital Advisors, LP held TNGX?
KVP Capital Advisors, LP has disclosed TNGX holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is KVP Capital Advisors, LP's current position in TNGX?
As of Q3 2026, KVP Capital Advisors, LP holds 230.26K shares of TNGX (TANGO THERAPEUTICS INC), valued at $5.75M, representing 4.70% of its reported portfolio and ranking #8.
Has KVP Capital Advisors, LP been buying or selling TNGX?
In the latest 13F filing (Q3 2026), KVP Capital Advisors, LP held unchanged its position in TNGX. The position peaked in Q2 2026 at 230.26K shares.
Which other funds hold TNGX?
Other major institutional holders of TNGX include Farallon Capital Management, RTW INVESTMENTS, LP, Boxer Capital Management, LLC, among 70 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.